Thus, with regards to breast cancer diagnosis, it is important to accurately determine HER2 expression level to receive appropriate drug dosage or avoid receiving ineffective drugs if the cancer is deemed to be HER2 negative. This evidence concerns the gene ERBB2 and breast carcinoma.